MarketPulse

regulatory prospects

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Inovio Faces Securities Fraud Lawsuit Over Misleading Statements on Drug Candidate

Class action lawsuit filed against Inovio Pharmaceuticals ($INO) for allegedly making false statements about INO-3107 treatment and manufacturing capabilities, causing significant stock declines.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Inovio Faces Securities Fraud Lawsuit Over INO-3107 Misstatements

Class action lawsuit filed against $INO for allegedly false statements about INO-3107 treatment and CELLECTRA device. Lead plaintiff deadline is April 7, 2026.
INOsecurities fraudclass action lawsuit